Clinical Trials Logo

CHILD B clinical trials

View clinical trials related to CHILD B.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01357486 Completed - Clinical trials for Hepatocellular Carcinoma

Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis

PRODIGE 21
Start date: November 14, 2011
Phase: Phase 2
Study type: Interventional

The incidence of Hepatocellular Carcinoma (HCC) is currently increasing in Europe and in France and about 2 / 3 of patients, are not eligible for curative treatment at the time of diagnosis. The palliative management of patients with advanced and symptomatic disease is complex and requires treatment combining anti-tumor activity and safety in patients with impaired liver functions. Sorafenib is the standard of care in a palliative setting, but the benefit of sorafenib in patient with altered liver function is uncertain. The aim of this trial is to study the interest of sorafenib in patients with HCC and impaired liver function compared to pravastatin (a drug with anti-tumoral activity in HCC) or to the combination sorafenib/pravastatin or to best supportive care (usually used in these patients).